Search results for “Androgen receptor activity” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 166 patents, we discovered top 34 key players by total patent application. Aragon Pharmaceuticals, Inc., Sloan-Kettering Institute for Cancer Research, Ligand Pharmaceuticals, Inc. are dominant in this area. They take 75.30% of the total patent filing.
Aragon Pharmaceuticals, Inc.
California, United States
Patent: 51
Sloan-Kettering Institute for Cancer Research
New York, United States
Patent: 47
Ligand Pharmaceuticals, Inc.
California, United States
Patent: 27
ESSA Pharma, Inc.
British Columbia, Canada
Patent: 17
Teijin Pharma Ltd.
Tokyo-to, Japan
Patent: 7
Sumitomo Chemical Co., Ltd.
Tokyo-to, Japan
Patent: 6
Provincial Health Services Authority
British Columbia, Canada
Patent: 6
Karobio AB
Sweden
Patent: 6
Kao Corp.
Tokyo-to, Japan
Patent: 5
Supadelixir, Inc.
South Korea
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 64 patents applied in the last 5 years. We discover 21 most active companies in this area. The fast-growing ESSA Pharma, Inc., University of British Columbia, Provincial Health Services Authority take 65.63% of patent filing during this period.
ESSA Pharma, Inc.
British Columbia, Canada
Patent: 17
University of British Columbia
British Columbia, Canada
Patent: 17
Provincial Health Services Authority
British Columbia, Canada
Patent: 8
BC Cancer Agency
British Columbia, Canada
Patent: 6
Sloan-Kettering Institute for Cancer Research
New York, United States
Patent: 6
Aragon Pharmaceuticals, Inc.
California, United States
Patent: 6
Supadelixir, Inc.
South Korea
Patent: 5
Shanghai Meizer Pharmaceuticals Co.,Ltd
China
Patent: 3
Arizona Board of Regents
Arizona, United States
Patent: 3
Institute of Medicinal Biotechnology Academy of Medical Scien
Beijing Shi, China
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 64 patents in last 5 years, we discover 11 new entrants. ESSA Pharma, Inc., Supadelixir, Inc., Shanghai Meizer Pharmaceuticals Co.,Ltd are the most active new entrants in this area.
ESSA Pharma, Inc.
British Columbia, Canada
Patent: 17
Supadelixir, Inc.
South Korea
Patent: 5
Shanghai Meizer Pharmaceuticals Co.,Ltd
China
Patent: 3
Arizona Board of Regents
Arizona, United States
Patent: 3
Zhejiang Normal University
Zhejiang Sheng, China
Patent: 2
Ubix Therapeutics Co. Ltd.
South Korea
Patent: 2
Shenzhen Endokai Pharmaceutical Technology Co., Ltd.
Guangdong Sheng, China
Patent: 2
Kronos Bio, Inc.
California, United States
Patent: 1
Korea Research Institute of Bioscience & Biotechnlogy
South Korea
Patent: 1
Korea Research Institute of Chemical Technology
South Korea
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 128 patents, we discovered top 7 universities and scientific research institutions by total patent application. University of British Columbia, Northwestern University, University of Rochester are dominant in this area. They take 110.16% of the total patent filing.
University of British Columbia
British Columbia, Canada
Patent: 47
Northwestern University
Illinois, United States
Patent: 5
University of Rochester
New York, United States
Patent: 2
Kanazawa University
Ishikawa-ken, Japan
Patent: 2
Zhejiang Normal University
Zhejiang Sheng, China
Patent: 2
Cornell University
New York, United States
Patent: 1
East China Normal University
Shanghai Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: